Ying Lu

2.9k total citations · 1 hit paper
81 papers, 1.9k citations indexed

About

Ying Lu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Ying Lu has authored 81 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 23 papers in Cancer Research and 16 papers in Surgery. Recurrent topics in Ying Lu's work include Cancer-related molecular mechanisms research (11 papers), Pediatric Hepatobiliary Diseases and Treatments (9 papers) and MicroRNA in disease regulation (7 papers). Ying Lu is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), Pediatric Hepatobiliary Diseases and Treatments (9 papers) and MicroRNA in disease regulation (7 papers). Ying Lu collaborates with scholars based in China, United States and Greece. Ying Lu's co-authors include Yongtao Xiao, Wei Cai, Min Xu, Aihua Gong, Kejun Zhou, Junbo He, F. Du, Jian Zeng, Ying Wang and Baofeng Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Ying Lu

74 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies

2025 19 citations Kai Meng, Hongyun Jia et al. Biomedicines profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ying Lu China	26	992	564	254	251	220	81	1.9k
Ye Cheng China	19	1.2k 1.2×	650 1.2×	275 1.1×	283 1.1×	142 0.6×	59	2.1k
Xiaodong Guo China	32	1.3k 1.3×	744 1.3×	182 0.7×	295 1.2×	232 1.1×	89	2.2k
Shan Deng China	26	1.1k 1.1×	514 0.9×	241 0.9×	488 1.9×	140 0.6×	71	2.0k
Chunyan Gu China	24	1.5k 1.5×	678 1.2×	142 0.6×	295 1.2×	368 1.7×	93	2.3k
Shuai Huang China	24	1.2k 1.2×	764 1.4×	145 0.6×	340 1.4×	181 0.8×	69	2.1k
Yuan Qin China	26	1.2k 1.2×	595 1.1×	258 1.0×	420 1.7×	128 0.6×	120	2.2k
Yongheng Bai China	26	990 1.0×	254 0.5×	254 1.0×	331 1.3×	205 0.9×	74	1.9k
Weikun Qian China	24	1.1k 1.1×	515 0.9×	238 0.9×	589 2.3×	208 0.9×	56	1.9k
Rui Liu China	24	1.5k 1.5×	937 1.7×	229 0.9×	336 1.3×	209 0.9×	93	2.4k
Haiquan Qiao China	29	1.2k 1.2×	710 1.3×	280 1.1×	504 2.0×	234 1.1×	60	2.3k

Countries citing papers authored by Ying Lu

Since Specialization

Citations

This map shows the geographic impact of Ying Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Lu more than expected).

Fields of papers citing papers by Ying Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Lu. The network helps show where Ying Lu may publish in the future.

Co-authorship network of co-authors of Ying Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Lu. A scholar is included among the top collaborators of Ying Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Lu. Ying Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meng, Kai, Hongyun Jia, Ying Lu, et al.. (2025). Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies. Biomedicines. 13(2). 327–327. 19 indexed citations breakdown →

Zhang, Ying, Haojie Yu, Wang Li, et al.. (2025). Research progress on conductive polymer-based microwave absorption materials: from materials design to functionalities and applications. Materials Horizons. 12(23). 10029–10058. 2 indexed citations

Li, Shihang, et al.. (2024). Curcumin modified Fe3O4 with efficient SDT for the treatment of breast cancer. Materials Letters. 381. 137721–137721. 2 indexed citations

Xiao, Yongtao, et al.. (2024). Farnesoid X receptor agonist tropifexor detoxifies ammonia by regulating the glutamine metabolism and urea cycles in cholestatic livers. European Journal of Pharmacology. 966. 176334–176334. 3 indexed citations

Yan, Weihui, Shanshan Chen, Ying Wang, et al.. (2024). Loss of Mptx2 alters bacteria composition and intestinal homeostasis potentially by impairing autophagy. Communications Biology. 7(1). 94–94. 5 indexed citations

Wu, Bo, et al.. (2024). Neurotensin contributes to cholestatic liver disease potentially modulating matrix metalloprotease-7. The International Journal of Biochemistry & Cell Biology. 170. 106567–106567. 2 indexed citations

Wei, Zihan, Ying Lu, Cheng Qian, Jing Li, & Xiaoli Li. (2024). Circ_0079480 facilitates proliferation, migration and fibrosis of atrial fibroblasts in atrial fibrillation by sponing miR-338-3p to activate the THBS1/TGF-β1/Smad3 signaling. International Journal of Cardiology. 416. 132486–132486. 3 indexed citations

Lu, Ying, Xiaomeng Li, Wei Yu, et al.. (2024). Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer. Prostate Cancer and Prostatic Diseases. 28(2). 260–269. 24 indexed citations

Wang, Ying, Ying Lu, Bo Wu, et al.. (2022). Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling. Cell Death and Disease. 13(11). 1001–1001. 7 indexed citations

10.

Wang, Ying, Ying Lu, Weipeng Wang, et al.. (2021). Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19. Cell Death and Disease. 12(7). 646–646. 31 indexed citations

11.

Xiao, Yongtao, Ying Wang, Liu Yang, et al.. (2021). A nonbile acid farnesoid X receptor agonist tropifexor potently inhibits cholestatic liver injury and fibrosis by modulating the gut–liver axis. Liver International. 41(9). 2117–2131. 35 indexed citations

12.

Tang, Ningning, Ling Li, Fei Xie, et al.. (2021). A living cell-based fluorescent reporter for high-throughput screening of anti-tumor drugs. Journal of Pharmaceutical Analysis. 11(6). 808–814. 5 indexed citations

13.

Li, Minle, Ying Lu, Yakui Li, et al.. (2019). Transketolase Deficiency Protects the Liver from DNA Damage by Increasing Levels of Ribose 5-Phosphate and Nucleotides. Cancer Research. 79(14). 3689–3701. 43 indexed citations

14.

Xiao, Yongtao, Runping Liu, Xiaojiaoyang Li, et al.. (2019). Long Noncoding RNA H19 Contributes to Cholangiocyte Proliferation and Cholestatic Liver Fibrosis in Biliary Atresia. Hepatology. 70(5). 1658–1673. 107 indexed citations

15.

Li, Yakui, Na Tian, Ping Zhang, et al.. (2019). The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation. Journal of Biological Chemistry. 294(40). 14745–14756. 31 indexed citations

16.

Xiao, Yongtao, Kejun Zhou, Ying Lu, et al.. (2018). Administration of antibiotics contributes to cholestasis in pediatric patients with intestinal failure via the alteration of FXR signaling. Experimental & Molecular Medicine. 50(12). 1–14. 65 indexed citations

17.

Xiao, Yongtao, Minghao Yin, Ying Lu, Kejun Zhou, & Wei Cai. (2018). PHB2 interacts with LC3 and SQSTM1 is required for bile acids-induced mitophagy in cholestatic liver. Cell Death and Disease. 9(2). 160–160. 62 indexed citations

18.

Cheng, Shengnan, et al.. (2018). Hydrogen sulfide inhibits epithelial-mesenchymal transition in peritoneal mesothelial cells. Scientific Reports. 8(1). 5863–5863. 19 indexed citations

19.

Liu, Xia, Fang Zhong, Fulin Lian, et al.. (2014). Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis. Acta Pharmacologica Sinica. 35(5). 697–706. 24 indexed citations

20.

Lu, Ying, Rongrong Cui, Yuan Liu, et al.. (2012). Apelin–APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-κB/JNK signal pathway in human umbilical vein endothelial cells. Amino Acids. 43(5). 2125–2136. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact